also reported AUCs of 0.75 and 0.81 for the efficacy of serum ATX in diagnosing liver fibrosis stages ≥ 2 in male and female NAFLD patients, respectively [52]. The gene discussed is ENPP2; the disease is metabolic dysfunction-associated steatotic liver disease.